Ads
related to: patent disputesforsalebyinventor.com has been visited by 10K+ users in the past month
Search results
Robert S. Mallin
The National Law Review· 4 hours agoPatent litigator Robert Mallin uses his experience as litigation strategist and first-chair trial attorney to maximize his clients’ returns in patent and ...
Federal Circuit Finds Declaratory Judgment Jurisdiction Over Patent Owner Through Amazon Apex...
The National Law Review· 4 hours agoOn 2 May 2024, the Federal Circuit entered its decision in SnapRays, dba SnapPower v. Lighting...
China’s Supreme People’s Court Releases Summary of the Supreme People’s Court’s Annual Report on...
The National Law Review· 4 hours agoOn April 24, 2024, China’s Supreme People’s Court (SPC) released the Summary of the Supreme People’s...
China’s National Intellectual Property Administration Releases Typical Cases of Administrative...
The National Law Review· 1 day agoAdministrative enforcement in China provides an alternative to enforcement through the court system and can be faster and less expensive than going to trial. The applicant, Wenzhou Chuangda ...
Ozempic maker Novo Nordisk denies flooding market with 'junk' patents after FTC challenge
Quartz· 1 day agoFederal Trade Commission’s (FTC) suggestion that it filed ‘junk’patents to prevent competition and...
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
Benzinga via Yahoo Finance· 3 days agoGeneric and biosimilar manufacturer Sandoz AG (OTC:SDZNY) (OTC:SDZXF) reached an agreement on...
Sandoz reaches agreement with Amgen over patent dispute
KFGO· 3 days agoZURICH (Reuters) - Swiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S. drugmaker Amgen resolving all patent litigation related ...
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle -...
Benzinga· 7 days agoCanadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV CVAC have settled...
FTC targets ‘junk patents’ on Ozempic, other top drugs
BioPharma Dive via Yahoo Finance· 2 days agoThe move broadens the antitrust regulator’s campaign against allegedly “improper or inaccurate” ...
Sandoz Reaches Agreement With Amgen Resolving All Patent Litigation
Morningstar· 3 days agoSandoz Group said that it has reached agreement with Amgen in the patent dispute over the company's denosumab biosimilars products, paving the way for it ...
